文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis.

作者信息

Dai Guangrong, Liu Pengfei, Li Xiaomei, Zhou Xiaoyan, He Shuixiang

机构信息

Department of Gastroenterology, Yanan University Affiliated Hospital, Yanan.

Department of Gastroenterology, Xi'an Jiaotong University First Affiliated Hospital, Xi'an, Shaanxi, China.

出版信息

Medicine (Baltimore). 2019 Feb;98(7):e14324. doi: 10.1097/MD.0000000000014324.


DOI:10.1097/MD.0000000000014324
PMID:30762732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6407996/
Abstract

OBJECTIVE: This meta-analysis is to investigate the relationship between the patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 polymorphism and the susceptibility and severity of nonalcoholic fatty liver disease (NAFLD). METHODS: Chinese Journal Full-text Database, Wanfang Database, VIP Database, and PubMed Database were subjected to case-control study retrieving, from January 2008 to December 2014. Following key words were used: fatty liver, PNPLA3, and rs738409 gene or variants or polymorphism or alleles. Meta-analysis was performed based on the retrieved articles. RESULTS: In total 65 studies were first retrieved according to the key words, and finally 21 studies with 14,266 subjects were included. Meta-analysis showed that PNPLA3 rs738409 polymorphism exerted strong influence not only on fatty liver but also on the histological injury. PNPLA3 rs738409 [G] allele was a risk factor for NAFLD (GG vs CC, OR = 4.01, 95% CI 2.93-5.49; GC vs CC, OR = 1.88, 95% CI 1.58-2.24). PNPLA3 gene variant was significantly associated with the increased serum alanine aminotransferase (ALT) levels (GG vs CC, standardized mean difference  = 0.47, 95% CI 0.14-0.81). In addition, nonalcoholic steatohepatitis (NASH) was more frequently observed in G allele carriers (GG vs CC, OR = 3.24, 95% CI 2.79-3.76; GC vs CC, OR = 2.14, 95% CI 1.43-3.19). CONCLUSION: PNPLA3 rs738409 polymorphism is not only a factor significantly associated with the susceptibility of NAFLD, but also related to the susceptibility of aggressive diseases.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/067ab83dd0ab/medi-98-e14324-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/0dbf735e8220/medi-98-e14324-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/656be16ece7b/medi-98-e14324-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/699087e5134d/medi-98-e14324-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/5f3555a3cb58/medi-98-e14324-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/2776353f767e/medi-98-e14324-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/3cebb3578f41/medi-98-e14324-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/c6e48ce6e354/medi-98-e14324-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/769fd0a8a900/medi-98-e14324-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/c653570b7c77/medi-98-e14324-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/067ab83dd0ab/medi-98-e14324-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/0dbf735e8220/medi-98-e14324-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/656be16ece7b/medi-98-e14324-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/699087e5134d/medi-98-e14324-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/5f3555a3cb58/medi-98-e14324-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/2776353f767e/medi-98-e14324-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/3cebb3578f41/medi-98-e14324-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/c6e48ce6e354/medi-98-e14324-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/769fd0a8a900/medi-98-e14324-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/c653570b7c77/medi-98-e14324-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297d/6407996/067ab83dd0ab/medi-98-e14324-g015.jpg

相似文献

[1]
Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis.

Medicine (Baltimore). 2019-2

[2]
Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.

BMC Med Genet. 2020-8-18

[3]
Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.

Hepatology. 2011-5-14

[4]
PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis.

J Gastroenterol Hepatol. 2015-5

[5]
Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.

BMC Med Genet. 2010-12-22

[6]
PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.

Surg Obes Relat Dis. 2015

[7]
[Association between patatin-like phospholipase domain-containing protein 3 gene rs738409 polymorphism and non-alcoholic fatty liver disease susceptibility: a meta-analysis].

Zhonghua Liu Xing Bing Xue Za Zhi. 2015-1

[8]
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.

J Hepatol. 2014-3-6

[9]
Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.

Medicine (Baltimore). 2016-3

[10]
The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.

Hepatology. 2016-1-14

引用本文的文献

[1]
() rs738409 Variant and Non-Alcoholic Fatty Liver Disease Risk in Vietnamese Working-Age Adults: A Case-Control Study with Metabolic Insights.

Clin Exp Gastroenterol. 2025-8-29

[2]
Genetic Risk of MASLD in Mongolians: Role of and SNPs.

Curr Issues Mol Biol. 2025-8-1

[3]
Impact of PNPLA3 I148M on Drug-Induced Hepatocellular Liver Injury: A Systematic Review and Meta-Analysis.

Liver Int. 2025-9

[4]
Gene-based therapies for steatotic liver disease.

Mol Ther. 2025-6-4

[5]
Genetic predisposition of metabolic dysfunction-associated steatotic liver disease: a population-based genome-wide association study.

Hepatol Int. 2025-4

[6]
The interplay between Helicobacter pylori infection and rs738409 PNPLA3 in metabolic dysfunction-associated steatotic liver disease.

PLoS One. 2024

[7]
The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics.

Proc Natl Acad Sci U S A. 2024-4-30

[8]
High red meat consumption among PNPLA3 polymorphism carriers is associated with NAFLD in a multi-center cross-sectional study.

Eur J Clin Nutr. 2024-5

[9]
Cryptogenic non-cirrhotic HCC: Clinical, prognostic and immunologic aspects of an emerging HCC etiology.

Sci Rep. 2024-2-21

[10]
Genetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review.

Transl Gastroenterol Hepatol. 2023-12-6

本文引用的文献

[1]
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.

World J Gastroenterol. 2016-9-28

[2]
PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.

Int J Mol Sci. 2016-4-27

[3]
Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.

Medicine (Baltimore). 2016-3

[4]
Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field.

World J Hepatol. 2015-10-28

[5]
PNPLA3 rs738409 Polymorphism Associated with Hepatic Steatosis and Advanced Fibrosis in Patients with Chronic Hepatitis C Virus: A Meta-Analysis.

Gut Liver. 2016-5-23

[6]
PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipients.

World J Gastroenterol. 2015-9-14

[7]
Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.

World J Gastroenterol. 2015-7-28

[8]
Understanding the pathophysiological mechanisms in the pediatric non-alcoholic fatty liver disease: The role of genetics.

World J Hepatol. 2015-6-18

[9]
Novel association between a nonsynonymous variant (R270H) of the G-protein-coupled receptor 120 and liver injury in children and adolescents with obesity.

J Pediatr Gastroenterol Nutr. 2014-10

[10]
Pediatric fatty liver disease: role of ethnicity and genetics.

World J Gastroenterol. 2014-6-21

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索